About 800,000 Nurses Planning to Leave the Profession by 2027, Data Show

Nearly 100,000 registered nurses were estimated to have left the field during the COVID-19 pandemic and almost 800,000 intend to follow them out by 2027, according to a survey analysis released Thursday by the National Council of State Boards of Nursing (NCSBN).

Responses to the poll of more than 50,000 nurses suggest a net nursing workforce decline of 3.3% in the past two years, and a 2.7% decline in registered nurses (RNs) specifically, according to data published in the Journal of Nursing Regulation.

“The data is clear: the future of nursing and of the U.S. healthcare ecosystem is at an urgent crossroads,” Maryann Alexander, chief officer of nursing regulation at NCSBN, said in an accompanying release.

Of particular concern to NCSBN’s researchers were the recent and planned departures of nurses who were relatively new to the field. RNs with 10 or fewer years of experience accounted for almost 41% of the total drop-off of practicing RNs, they wrote. Another 15.2% said they planned to leave in the next five years, resulting in a net decline of 188,962 nurses.

On the other end of the spectrum, 44.8% of RNs with over 10 years of experience said they will likely leave in the next five years. This would subtract another 610,388 RNs from the workforce, according to the researcher’s nationally weighted estimate.

Comparable declines also came among the survey’s support nurse respondents. Per the data, 4.2% (or an estimated 33,811) of licensed practical nurses/licensed vocational nurses left the workforce in the past two years—an issue compounded by “considerable and somewhat unprecedented disruptions” to prelicensure nursing education programs during the past few years.

The departures are likely tied to feelings of burnout and exhaustion reported by many of the responding nurses, researchers wrote.

Sixty-two percent of the sample said their workload had increased during the pandemic and others reported feeling emotionally drained (50.8%), fatigued (49.7%) or burned out (45.1%) at least a few times each week, according to the survey results. Free responses solicited from the nurses also frequently mentioned keywords related to COVID-19 stress (20.2%), unsafe staffing or work environments (23.2%), underappreciation (22.6%) and compensation (17.5%).

“The pandemic has stressed nurses to leave the workforce and has expedited an intent to leave in the near future, which will become a greater crisis and threaten patient populations if solutions are not enacted immediately,” NCSBN’s Alexander said. “There is an urgent opportunity today for health care systems, policymakers, regulators and academic leaders to coalesce and enact solutions that will spur positive systemic evolution to address these challenges and maximize patient protection in care into the future.”

 

Source Link

Recommended Articles

P4ESC Warns Congress Not to Tax Health Benefits

“We oppose taxing health benefits,” said Neil Trautwein, P4ESC’s Executive Director. “Policymakers will find how widely unpopular the idea will be with Americans with this type of coverage if they take this unwise step,” added Trautwein.

Read More

At Social Security, These Are the Days of the Living Dead

In multiple instances over the past few weeks, Social Security Offices have seen people come in for whom “there is no information on the record, just that they are dead.” So employees have to “resurrect” them — affirm that they’re living, so they can receive their benefits.

Read More

Out-Of-Pocket Drug Spending Hit $98B In 2024: Report

Americans spent $98 billion out of pocket on prescription drugs in 2024, marking a cumulative 25% increase over five years, according to an annual report from analytics firm IQVIA. Why it matters: Lowering prescription drug costs remains a priority for both Democrats and Republicans. The Biden administration led Congress in passing a landmark legislative package to negotiate select drug ...

Read More

Trump Signs Executive Order To Encourage U.S. Drug Manufacturing

U.S. President Donald Trump signed an executive order on Monday that aims to reduce the time it takes to approve pharmaceutical plants in the country, as part of new regulations to encourage domestic manufacturing. The order directs the U.S. Food and Drug Administration to streamline reviews and work with domestic manufacturers to provide early support ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square